SBX.DE
SynBiotic SE [SBX.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SBX.DE Stock Summary
Top 10 Correlated Stocks
SBX.DE
In the News
SBX.DE Financial details
Company Rating
-
Market Cap
52.34M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
104
Optionable
No
Shortable
Yes
Earnings
23 Aug 2023
P/E
0
Forward P/E
-
PEG
-
P/S
1.94
P/B
-
P/C
-
P/FCF
-2.12
Quick Ratio
0.62
Current Ratio
1.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
40.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.31%
SMA50
-19.95%
SMA100
-42.37%
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-85%
ROC
-0.71%
Gross Margin
44%
Oper. Margin
-301%
Profit Margin
-298%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.86-19.5
52W High
-81.21%
52W Low
+78.5%
RSI
59.21
Rel Volume
0.02
Avg Volume
67.56K
Volume
1.36K
Perf Week
8.18%
Perf Month
-0.56%
Perf Quarter
-40.5%
Perf Half Y
-46.56%
-
-
-
-
Beta
5.19786
-
-
Volatility
0.22%, 0.18%
Prev Close
1.71%
Price
3.57
Change
16.67%
Company Profile
- Volume Average 67.56K
- Market Capitalization 52.34M
- Employee 104
- CEO Mr. Lars Muller
- Headquarters Munich,DE
- IPO Date 2021-01-07
-
Website
https://www.synbiotic.com 
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
